You are here » Home » Companies » Company Overview » Venmax Drugs & Pharmaceuticals Ltd

Venmax Drugs & Pharmaceuticals Ltd.

BSE: 531015 Sector: Health care
NSE: N.A. ISIN Code: INE154G01022
BSE LIVE 13:06 | 24 Nov 2.49 0
(0.00%)
OPEN

2.49

HIGH

2.49

LOW

2.49

NSE LIVE 05:30 | 01 Jan Stock Is Not Traded.
OPEN 2.49
PREVIOUS CLOSE 2.49
VOLUME 220
52-Week high 3.00
52-Week low 2.33
P/E
Mkt Cap.(Rs cr) 1.30
Buy Price 0.00
Buy Qty 0.00
Sell Price 2.49
Sell Qty 280.00
OPEN 2.49
CLOSE 2.49
VOLUME 220
52-Week high 3.00
52-Week low 2.33
P/E
Mkt Cap.(Rs cr) 1.30
Buy Price 0.00
Buy Qty 0.00
Sell Price 2.49
Sell Qty 280.00

About Venmax Drugs & Pharmaceuticals Ltd.

Venmax Drugs & Pharmaceuticals Ltd

Venmax Drugs and Pharmaceuticals Limited was incorporated in the year 1988. The company engages in the manufacture and sale of bulk drugs intermediates primarily in India. Its drug intermediates include trityl chloride. The company was formerly known as Yenkey Drugs and Pharmaceuticals Limited. Venmax Drugs and Pharmaceuticals Limited is based in Hyderabad, India....> More

Venmax Drugs & Pharmaceuticals Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   1
EPS - TTM () [*S] -
P/E Ratio (X) [*S] -
Face Value ()   10
Latest Dividend (%)   -
Latest Dividend Date -
Dividend Yield (%) 0.00
Book Value / Share () [*S] 0.30
P/B Ratio () [*S] 8.30
[*C] Consolidated     [*S] Standalone

Venmax Drugs & Pharmaceuticals Ltd - Financial Results

Particulars ( cr) Sep 2016 Sep 2015 % Chg
Net Sales 0.09 0.12 -25
Other Income -
Total Income 0.09 0.12 -25
Total Expenses 0.13 0.12 8.33
Operating Profit -0.04 -0.01 -300
Net Profit -0.04 -0.01 -300
Equity Capital 5.24 5.24 -
> More on Venmax Drugs & Pharmaceuticals Ltd Financials Results

Venmax Drugs & Pharmaceuticals Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Surya Pharma. 0.16 -5.88 3.24
Ganga Pharma. 7.51 -4.82 3.05
Hind.Bio Science 2.34 0.00 2.40
Pharmaids Pharma 3.80 0.00 1.30
Venmax Drugs 2.49 0.00 1.30
Raymed Labs 2.85 -4.36 1.22
Veerhealth Care 1.42 4.41 0.98
> More on Venmax Drugs & Pharmaceuticals Ltd Peer Group

Venmax Drugs & Pharmaceuticals Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 23.14
Banks/FIs 0.15
FIIs 0.00
Insurance 0.00
Mutual Funds 0.00
Indian Public 65.04
Custodians 0.00
Other 11.68
> More on Venmax Drugs & Pharmaceuticals Ltd Share Holding Pattern

Venmax Drugs & Pharmaceuticals Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week NA NA 0.00% 0.01%
1 Month NA NA -3.23% -3.45%
3 Month NA NA -8.92% -8.94%
6 Month NA NA -1.44% -0.71%
1 Year NA NA 2.94% 4.64%
3 Year NA NA 25.70% 30.08%

Venmax Drugs & Pharmaceuticals Ltd - STOCK STRENGTH

Today's Low/High 2.49
2.49
Week Low/High 0.00
2.49
Month Low/High 2.49
2.00
YEAR Low/High 2.33
3.00
All TIME Low/High 1.10
18.00

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard